Other languages Nymox Pharmaceutical Corporation

Equities

NYMX.F

BSP733981026

Market Closed - OTC Markets Other stock markets 17:12:23 27/06/2024 BST			5-day change	1st Jan Change
0.205 ^USD	-14.41%		+38.51%	-65.25%

2023	Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15
Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	25/09/23
Nymox Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Nymox Pharmaceutical Corporation Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results	25/07/23
Nymox Pharmaceutical Corporation Appoints Patrick Doody as Vice President, General Counsel and Member of Board of Directors	12/07/23
Fed Outlook Weighs on Exchange-Traded Funds, Equity Futures Premarket Thursday	06/07/23
Nymox Pharmaceutical Receives Delisting Notice From Nasdaq	06/07/23
Nymox Pharmaceutical Corporation Announces Removal of Board of Directors	27/06/23
Nymox Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Nymox Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	02/05/23
Nymox Pharmaceutical Corporation Auditor Raises 'Going Concern' Doubt	01/05/23
Nymox Pharmaceutical Names Christopher Riley as CFO	21/03/23
Nymox Pharmaceutical Gets Nasdaq Extension to Comply With Listing Requirements; Shares Rise	15/03/23
Nymox Pharmaceutical Corporation Announces New Marketing Submission for Nymozarfex for BPH	05/12/22
Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	16/11/22
Nymox Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22
Nymox Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22
Nymox Pharmaceutical Says on Track With Business Plan Development; Shares Rise	15/07/22
Nymox Pharmaceutical Receives Deficiency Notice From NASDAQ Over Minimum Bid Price; Shares Fall Midday	14/07/22
Nymox Pharmaceutical Gets FDA Refusal to File Letter for Prostate Enlargement Treatment Application; Shares Fall	23/05/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nymox Pharmaceutical Corporation

Equities

NYMX.F

BSP733981026

Other languages

Filters